Research indicates that the new Retatrutide – which was created by the Mongro -Mongro -Mongro -drug, can make patients lose dangerous amounts of weight.
Early experiments of the drug, Ritatrotide, have shown that people can help get rid of a quarter of body weight in less than a year, which is close to the weak effectiveness of Osmbek.
But scientists have now discovered anxious complications of losing fat caused by the drug, such as bone fracture and kidney stones.
In a difference with other slimming injections, the injection made by “Eli Lily” company not only suppresses appetite, but also works to accelerate metabolism.
However, the volunteers in the latest clinical trial claimed that they had lost a lot of fat very quickly.
It was reported that one of the participants lost 22% of her weight in only 9 months. Another was injured, as nearly a third of his weight in 8 months has been with a possible serious kidney stones.
On social media, users who claimed that they obtained the experimental medicine – although it was not yet approved for use in the United States or the United Kingdom – boasted more than 20 kilograms of using injections within months.
Quarter of weight
Early experiments of Ritatrotide have already shown that it can help people get rid of a quarter of their bodies in less than a year.
The owner of an American account claimed that he was taking the property for 3 weeks, and lost 7 pounds in this period.
The injection that is eaten once a week was called “Triple G” because it targets 3 different hormones that participate in the amount of food we eat.
Unlike other slimming injections, the injection made by Eli Lily not only suppresses appetite, but also accelerates metabolism.
By comparison, it targets OzemPIC and a single -hormonal Wegovic, and the drug Mountaro targets two hormones.
The identity of all participants, whose ages ranged between the 1940s and 1950s, can not be identified due to the confidential agreements signed when registering in studies.
The owner of one of the other British accounts that urged people to “start a weight loss journey today” said that she was using a dose of 20 mg – the highest strength – for 4 months.
Elie Lily said it will not comment on the ongoing Ritatrotide experience protocols, according to Daily Mail from State News.
The giant pharmaceutical company added in a statement that the safety of patients was at the top of its priorities, and “we are actively participating in monitoring, evaluation and reporting safety information for all our medications.”
Dr. John Batses, assistant professor of medicine at the University of North Carolina, said that he treated a couple of patients who became weak and fell after losing a lot of weight using current treatments, including a sick person who broke her swarm.
Experts have always warned of the risk of rapid and severe weight loss, which can include pancreatitis, as well as gallbladder stones, muscle mass loss and bone density changes.
“The amount of extra weight loss is unknown, and we really need additional data and we need studies to consider this.”
The results of Eli Lily’s experience, which was published in the New England Medical Magazine last year, continued 338 adults suffering from weight gain and obesity for 48 weeks. Those who took the highest dose of the weekly injection – 12 mg – lost approximately 25% of their bodies by the end of the study.
Side effects
Women who took Ritatrotide have lost 28.5% of their bodies over 48 weeks. By comparison, men lost 21.2%.
More participants with obesity lost a greater percentage of their bodies by 26.5% in 48 weeks.
At the end of 48 weeks, the amount of weight lost did not reach a fixed level, indicating that people could have lost more weight if they continued to take the medicine for a longer period.
Like all the previous GLP-1 drugs, the drug Ritatrotide, which is taken once a week, has led to side effects, including nausea, diarrhea and constipation.
But the study showed that the drug also has other health benefits.
Participants have witnessed a great improvement in blood pressure and blood sugar levels, and 4 out of 10 participants were able to stop taking medications to treat high blood pressure.
In comparison, experiments on the drug Simaglotide – formed in Ozmbek – showed that it can help users get rid of up to 15% of body weight over 68 weeks.
Studies have found that Monjaro can help people with obesity get rid of up to 22.5% of body weight in 72 weeks.